CATEGORIE

Groundbreaking POC hemostasis diagnostic to be presented at Major European Meetings

domenica 27 maggio 2018

2' di lettura

- ESA Exhibit Location: C2-040ESA Poster Details: A Novel Differential Assay to Quantify Fibrinolytic Function in Whole Blood with the Quantra Hemostasis Analyzer, June 2, 14:00-15:30; Poster e-Board 5. In addition, HemoSonics will be demonstrating the Quantra at the International Society on Thrombosis and Haemostasis Scientific Subcommittee (ISTH SSC) meeting on July 18-21 in Dublin, Ireland.  HemoSonics is partnering with Stago on the symposium "The Role of the Core Lab and Point-Of-Care Testing in Managing Bleeding Disorders Benefits and Challenges." The Company welcomes congress attendees to the Stago/HemoSonics booth where the Quantra will be demonstrated and members of the team will be available to answer clinical and scientific questions. ISTH SSC Exhibit Location: H1 in the Forum, Ground FloorISTH Sponsored Symposium: Liffey Hall, July 18 13:15-14:30 About the Quantra™ SystemThe Quantra system is a rapid, easy-to-use diagnostic platform that utilizes consumable cartridges to run a panel of tests. The initial QPlus™ Cartridge measures the treatable aspects of coagulation in under 15 minutes. The Quantra Hemostasis Analyzer is designed for use in critical care settings which require that results be generated quickly from an instrument that is easy to operate at the point of care. The Quantra System is commercially available in Europe. About HemoSonicsHemoSonics is a medical device company offering a novel point-of-care diagnostic platform to guide the management of critical bleeding to improve outcomes and reduce healthcare costs by enabling more targeted transfusion of blood products. The Quantra System is designed to transform the way clinicians manage coagulation dysfunctions by providing comprehensive, timely information on coagulation status at the point of care. HemoSonics is headquartered in Charlottesville, VA, with research, development and manufacturing facilities in Durham, NC. For more information, visit www.hemosonics.com. ContactRemi CorlinHemoSonicsVP International Marketscontact@hemosonics.com

tag

Ti potrebbero interessare

TRENORD, NEL 2025 780MILA CORSE E 205 MILIONI DI PASSEGGERI

Nel 2025 Trenord ha effettuato 780mila corse, il 3% in più rispetto al 2024, per 205 milioni di passeggeri. &Egra...
Redazione

MILANO HOME 2026: HUMAN RETAIL, UNA NUOVA CULTURA DEL NEGOZIO PER L’ABITARE CONTEMPORANEO

Oltre 750 brand presenti, con una crescita superiore al 20% rispetto al 2025, e una presenza internazionale che supera i...
Redazione

A REBIBBIA FOCUS SULLA CULTURA ALIMENTARE E LE OPPORTUNITÀ DEL CIBO

Una dieta sana, equilibrata e gustosa può davvero essere alla portata di tutti? Cosa occorre sapere per scegliere...

IL LABORATORIO ANTIDOPING FMSI DI ROMA APPROVATO DALLA WADA PER I GIOCHI OLIMPICI E PARALIMPICI DI MILANO CORTINA 2026

Dopo l’inaugurazione della nuova sede di via delle Rupicole avvenuta lo scorso dicembre, frutto di un intervento d...
Redazione